The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
Abstract
Background. The long-term use of methamphetamine (MAMP) can result in psychosis but it is not clear why some individuals develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We set out to characterize MAMP users and to examine the relationship of pre-morbid personality, pre-morbid social function and other psychiatric disorders to MAMP psychosis. Method. Four hundred and forty-five amphetamine users were recruited from a psychiatric hospital and a detention centre in Taipei, and were assessed with the Diagnostic Interview for Genetic Studies (DIGS). Their parents were interviewed with the Premorbid Schizoid and Schizotypal Traits (PSST) and the Premorbid Social Adjustment (PSA) schedules. Pre-morbid characteristics and psychiatric co-morbidity were compared between the MAMP users with a lifetime diagnosis of MAMP psychosis and those without. Results. The MAMP users with psychosis presented a clinical picture which mimicked the positive symptoms of schizophrenia: 85% had auditory hallucinations; 71% persecutory delusions; 63% delusions of reference. Compared with their non-psychotic counterparts, these MAMP users were younger at first MAMP use, used larger amounts of MAMP, had a significantly higher mean PSST score, and higher rates of major depressive disorder, alcohol dependence and antisocial personality disorder. Conclusions. Earlier and larger use of MAMP was associated with increased risk of psychosis. Our data are also compatible with the view that pre-morbid schizoid/schizotypal personality predisposes MAMP users to develop psychosis, and that the greater the personality vulnerability, the longer the psychosis will persist.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, it must account for the excessive dopamine neurotransmission that has been associated with the psychotic symptoms of schizophrenia.”
From Schizophrenia, myelination, and delayed corollary discharges: a hypothesis (2012) · cites this paper as [3]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Diagnostic Interview for Genetic Studies
Nürnberger, J. I. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110009002 · Cited by 2,075
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
The Prevalence of Psychiatric Disorders in Patients With Alcohol and Other Drug Problems
Ross, H. E. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800350057008 · Cited by 724
Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
LINSZEN, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 665
Amphetamine Psychosis: A "Model" Schizophrenia Mediated by Catecholamines
Snyder, S. H. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.61 · Cited by 588
Heterogeneity of Psychiatric Diagnosis in Treated Opiate Addicts
Rounsaville, B. J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020027006 · Cited by 558
Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule
Hwu, H., Yeh, E., & Chang, L. ‐. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb08581.x · Cited by 472
Cited by
Sorted by citations
A review of the clinical pharmacology of methamphetamine
Cruickshank, C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 802
Major physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 669
Comorbidity between substance use disorders and psychiatric conditions.
Schuckit, M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01592.x · Cited by 434
Implications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 396
The prevalence of psychotic symptoms among methamphetamine users
McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01496.x · Cited by 393
Methamphetamine and cardiovascular pathology: a review of the evidence
Kaye, S., McKetin, R., Duflou, J., & Darke, S. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01874.x · Cited by 319
Methamphetamine Psychosis: Epidemiology and Management
Glasner-Edwards, S., & Mooney, L. J. (2014) · CNS Drugs · doi:10.1007/s40263-014-0209-8 · Cited by 266
Reasons for increased substance use in psychosis
Gregg, L., Barrowclough, C., & Haddock, G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.004 · Cited by 249
Bramness, J. G., Gundersen, Ø. H., Guterstam, J., Rognli, E. B., Konstenius, M., Løberg, E., Medhus, S., Tanum, L., & Franck, J. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-221 · Cited by 244
Methamphetamine-Associated Psychosis
Grant, K. M., LeVan, T. D., Wells, S. M., Li, M., Stoltenberg, S. F., Gendelman, H. E., Carlo, G., & Bevins, R. A. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9288-1 · Cited by 235
Paparelli, A., Forti, M. D., Morrison, P. D., & Murray, R. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00001 · Cited by 219
Self-citationWhat causes the onset of psychosis?
Broome, M. R., Woolley, J. B., Tabraham, P., Johns, L. C., Bramon, E., Murray, G. K., Pariante, C., McGuire, P. K., & Murray, R. M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.007 · Cited by 207
Self-citationPathways to schizophrenia: the impact of environmental factors
Howes, O. D., McDonald, C., Cannon, M. D., Arseneault, L., Boydell, J. E., & Murray, R. M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004122 · Cited by 208
Self-citationVearrier, D., Greenberg, M. I., Miller, S. N., Okaneku, J., & Haggerty, D. A. (2012) · Disease-a-Month · doi:10.1016/j.disamonth.2011.09.004 · Cited by 191
Environmental risk factors for psychosis
Dean, K., & Murray, R. M. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.1/kdean · Cited by 198
Self-citationBlack, D. W., Gunter, T., Loveless, P., Allen, J., & Sieleni, B. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200206 · Cited by 169
Borderline personality disorder in male and female offenders newly committed to prison.
Black, D., Gunter, T., Allen, J., Blum, N., Arndt, S., Wenman, G., & Sieleni, B. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.04.006 · Cited by 182
Neurologic Manifestations of Chronic Methamphetamine Abuse
Rusyniak, D. E. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.02.005 · Cited by 164
The neurobiology of methamphetamine induced psychosis
Hsieh, J. H., Stein, D. J., & Howells, F. M. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00537 · Cited by 160
Chen, C., Lin, S., Sham, P. C., Ball, D., Loh, E., & Murray, R. M. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30187 · Cited by 156
Self-citationPsychiatric comorbidity in methamphetamine dependence
Salo, R., Flower, K., Kielstein, A., Leamon, M. H., Nordahl, T. E., & Galloway, G. P. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.09.014 · Cited by 151
van Os, J., Krabbendam, L., Myin‐Germeys, I., & Delespaul, P. (2005) · Current Opinion in Psychiatry · doi:10.1097/00001504-200503000-00006 · Cited by 146
Substance-Induced Psychoses: An Updated Literature Review
Fiorentini, A., Cantù, F., Crisanti, C., Cereda, G., Oldani, L., & Brambilla, P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.694863 · Cited by 135
Wearne, T. A., & Cornish, J. L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00491 · Cited by 144
Schizophrenia: From developmental deviance to dopamine dysregulation
Murray, R. M., Lappin, J., & Forti, M. D. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.04.002 · Cited by 142
Self-citationSchizophrenia, myelination, and delayed corollary discharges: a hypothesis
Whitford, T. J., Ford, J. M., Mathalon, D. H., Kubicki, M., & Shenton, M. E. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq105 · Cited by 140
The Assessment of Schizotypy and Its Clinical Relevance
Mason, O. J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu194 · Cited by 141
The epidemology of schizophrenia: replacing dogma with knowledge
Stilo, S. A., & Murray, R. M. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/sstilo · Cited by 140
Self-citation(2008) · PubMed · Cited by 128
Pharmacotherapy of amphetamine‐type stimulant dependence: An update
Brensilver, M., Heinzerling, K. G., & SHOPTAW, S. J. (2013) · Drug and Alcohol Review · doi:10.1111/dar.12048 · Cited by 125
Rose, M. E., & Grant, J. E. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230802177656 · Cited by 121
Neurologic Manifestations of Chronic Methamphetamine Abuse
Rusyniak, D. E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.05.004 · Cited by 129
A systematic review of risk factors for methamphetamine-associated psychosis
Arunogiri, S., Foulds, J., McKetin, R., & Lubman, D. I. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417748750 · Cited by 118
Emerging research on methamphetamine
Maxwell, J. C. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165592.52811.84 · Cited by 116
Risk factors for schizophrenia — All roads lead to dopamine
Forti, M. D., Lappin, J., & Murray, R. M. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.005 · Cited by 116
Self-citationKhat use and neurobehavioral functions: Suggestions for future studies
Hoffman, R., & Al’Absi, M. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.05.033 · Cited by 114
Correlates of Rural Methamphetamine and Cocaine Users: Results From a Multistate Community Study
Booth, B. M., Leukefeld, C. G., Falck, R. S., Wang, J., & Carlson, R. G. (2006) · Journal of Studies on Alcohol · doi:10.15288/jsa.2006.67.493 · Cited by 109
Shin, E., Dang, D., Tran, T.-V., Tran, H., Jeong, J. H., Nah, S.-Y., Jang, C., Yamada, K., Nabeshima, T., & Kim, H. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0897-y · Cited by 106
The profile of psychiatric symptoms exacerbated by methamphetamine use
McKetin, R., Dawe, S., Burns, R. A., Hides, L. M., Kavanagh, D. J., Teesson, M., Young, R. M., Voce, A., & Saunders, J. B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.01.018 · Cited by 105
Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service
Tanner‐Smith, E. E. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.016 · Cited by 100
The risk of psychotic symptoms associated with recreational methamphetamine use
McKetin, R., HICKEY, K., Devlin, K., & LAWRENCE, K. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00160.x · Cited by 99
Long‐term outcomes in methamphetamine psychosis patients after first hospitalisation
Kittirattanapaiboon, P., Mahatnirunkul, S., Booncharoen, H., THUMMAWOMG, P., DUMRONGCHAI, U., & Chutha, W. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00196.x · Cited by 98
Grace, A. A. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9154-6 · Cited by 100
Radfar, S. R., & Rawson, R. A. (2014) · PubMed Central · Cited by 97
Psychostimulant use and the brain
Lappin, J., & Sara, G. E. (2019) · Addiction · doi:10.1111/add.14708 · Cited by 103
Psychosis among substance users
Thirthalli, J., & Benegal, V. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218593.08313.fd · Cited by 94
Akiyama, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.012 · Cited by 86
Lin, S., Ball, D., Hsiao, C., Chiang, Y.-L., Ree, S., & CHEN, C. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2003.01218.x · Cited by 84
Self-citationNeuropsychiatric Adverse Effects of Amphetamine and Methamphetamine
Harro, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.004 · Cited by 84
Clinical course and outcomes of methamphetamine-dependent adults with psychosis
Glasner, S. V., Mooney, L. J., Marinelli‐Casey, P., Hillhouse, M. P., Ang, A., & Rawson, R. A. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.004 · Cited by 76
The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis
Lecomte, T., Dumais, A., Dugre, J. R., & Potvin, S. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.033 · Cited by 75
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
Voce, A., Calabria, B., Burns, R. A., Castle, D. J., & McKetin, R. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2018.1521430 · Cited by 75
Giordano, G. N., Ohlsson, H., Sundquist, K., Sundquist, J., & Kendler, K. S. (2015) · Psychological Medicine · doi:10.1017/s0033291714001524 · Cited by 74
Sara, G. E., Large, M. M. B., Matheson, S. L., Burgess, P. M., Malhi, G. S., Whiteford, H., & Hall, W. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414561526 · Cited by 73
Ding, Y., Lin, H., Zhou, L., Yan, H., & He, N. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.06.042 · Cited by 72
Frankel, P. S., Alburges, M. E., Bush, L. G., Hanson, G. R., & Kish, S. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.019 · Cited by 72
Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options
Chiang, M., Lombardi, D., Du, J., Makrum, U., Sitthichai, R., Harrington, A., Shukair, N., Zhao, M., & Fan, X. (2019) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2710 · Cited by 71
Rawson, R. A. (2013) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2013.09.039 · Cited by 71
Predictors of psychosis severity in individuals with primary stimulant addictions
Lichlyter, B., Purdon, S. E., & Tibbo, P. G. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.08.019 · Cited by 70
Substance use in adolescence and psychosis: clarifying the relationship.
Barkus, E., & Murray, R. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131220 · Cited by 70
Self-citationAmphetamine psychosis: a model for studying the onset and course of psychosis
Hermens, D. F., Lubman, D. I., Ward, P. B., Naismith, S. L., & Hickie, I. B. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02370.x · Cited by 67
Grelotti, D. J., Kanayama, G., & Pope, H. G. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08111695 · Cited by 67
What can we learn about schizophrenia from studying the human model, drug‐induced psychosis?
Murray, R. M., Paparelli, A., Morrison, P. D., Marconi, A., & Forti, M. D. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32177 · Cited by 72
Self-citationPresynaptic Regulation of Dopamine Transmission in Schizophrenia
Lyon, G. J., Abi‐Dargham, A., Moore, H. M., Lieberman, J. A., Javitch, J. A., & Sulzer, D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp010 · Cited by 71
Cheng, W.-J., Chen, C.-H., Chen, C.-K., Huang, M.-C., Pietrzak, R. H., Krystal, J. H., & Xu, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.049 · Cited by 65
Self-citationThe impact of methamphetamine (“tik”) on a peri-urban community in Cape Town, South Africa
Watt, M. H., Meade, C. S., Kimani, S., MacFarlane, J. C., Choi, K. W., Skinner, D. G., Pieterse, D., Kalichman, S. C., & Sikkema, K. J. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.10.007 · Cited by 63
DSM-V Research Agenda: Substance Abuse/Psychosis Comorbidity
Rounsaville, B. J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm054 · Cited by 62
Substance Misuse and Early Psychosis
Tucker, P. (2009) · Australasian Psychiatry · doi:10.1080/10398560802657314 · Cited by 61
McKetin, R., Baker, A., Dawe, S., Voce, A., & Lubman, D. I. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.028 · Cited by 59
Selemon, L. D., Begović, A., Goldman‐Rakic, P. S., & Castner, S. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301179 · Cited by 58
Manning, E. E., & van den Buuse, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00092 · Cited by 57
Medhus, S., Mordal, J., Holm, B., Mørland, J. G., & Bramness, J. G. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.023 · Cited by 57
Sulaiman, A. H., Said, M. A., Habil, M. H., Rashid, R. B. A., Nordin, A. S. A., Ng, C. G., Midin, M., Jaafar, N. R. N., Sidi, H., & Das, S. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.01.003 · Cited by 57
Lecomte, T., Mueser, K. T., MacEwan, W. G., Thornton, A. E., Buchanan, T., Bouchard, V., Goldner, E. M., Brink, J., Lang, D. J., Kang, S., et al. (2013) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000059 · Cited by 56
A putative animal model of the “prodromal” state of schizophrenia
Tenn, C. C., Fletcher, P. J., & Kapur, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.013 · Cited by 56
Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users
Chen, C., Lin, S., Chen, Y., Huang, M., Chen, T., Ree, S., & Wang, L. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.12.035 · Cited by 55
Self-citationKhat use and psychotic symptoms in a rural Khat growing population in Kenya: a household survey
Ongeri, L., Kirui, F., Muniu, E. M., Manduku, V., Kirumbi, L., Atwoli, L., Agure, S., Wanzala, P., Kaduka, L. U., Karimi, M., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2118-3 · Cited by 52
Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China
Zhang, Y., Lu, C., Zhang, J., Li, H., Song, H., Li, J., & Kang, L. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.06.024 · Cited by 51
Pogorelov, V. M., Nomura, J., Kim, J., Kannan, G., Ayhan, Y., Yang, C., Taniguchi, Y., Abazyan, B. N., Valentine, H., Krasnova, I. N., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.003 · Cited by 52
Differences in associations between cannabis and stimulant disorders in first admission psychosis
Sara, G. E., Burgess, P. M., Malhi, G. S., Whiteford, H., & Hall, W. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.017 · Cited by 50
Primary and substance-induced psychotic disorders in methamphetamine users
Hides, L. M., Dawe, S., McKetin, R., Kavanagh, D. J., Young, R. M., Teesson, M., & Saunders, J. B. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.077 · Cited by 50
Behavioral regulation in methamphetamine abusers: An fMRI study
Salo, R. E., Fassbender, C., Buonocore, M. H., & Ursu, S. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.10.003 · Cited by 50
Drugs of abuse and increased risk of psychosis development
Gururajan, A., Manning, E. E., Klug, M., & van den Buuse, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412455232 · Cited by 50
Causes of death of patients with methamphetamine dependence: A record-linkage study
Kuo, C., Liao, Y., Chen, W. J., Tsai, S., Lin, S., & Chen, C. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00255.x · Cited by 49
Self-citationInjury associated with methamphetamine use: A review of the literature
Sheridan, J. L., Bennett, S., Coggan, C. A., Wheeler, A., & McMillan, K. (2006) · Harm Reduction Journal · doi:10.1186/1477-7517-3-14 · Cited by 48
Li, H., Lu, Q., Xiao, E., Li, Q., He, Z., & Mei, X. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900206 · Cited by 47
Wouldes, T. A., LaGasse, L. L., Derauf, C., Newman, E., Shah, R., Smith, L. M., Arria, A. M., Huestis, M. A., DellaGrotta, S. A., Wilcox, T., et al. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.06.016 · Cited by 46
Kalayasiri, R., Verachai, V., Gelernter, J. E., Mutirangura, A., & Malison, R. T. (2014) · Addiction · doi:10.1111/add.12512 · Cited by 45
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
Chana, G., Bousman, C., Money, T., Gibbons, A. S., Gillett, P., Dean, B., & Everall, I. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00095 · Cited by 44
Swanepoel, T., Möller, M., & Harvey, B. H. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4776-5 · Cited by 46
Ma, J., Sun, X.-J., Wang, R., Wang, T., Su, M.-F., Liu, M.-X., Li, S., Han, Y., Meng, S., Wu, P., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.017 · Cited by 44
Clinical features of inpatients with methamphetamine-induced psychosis
Fasihpour, B., Molavi, S., & Shariat, S. V. (2013) · Journal of Mental Health · doi:10.3109/09638237.2012.745184 · Cited by 42
Wearne, T. A., Mirzaei, M., Franklin, J. L., Goodchild, A. K., Haynes, P. A., & Cornish, J. L. (2014) · Journal of Proteome Research · doi:10.1021/pr500719f · Cited by 41
Avram, M., Müller, F., Rogg, H. V., Korda, A. I., Andreou, C., Holze, F., Vizeli, P., Ley, L., Liechti, M. E., & Borgwardt, S. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.04.003 · Cited by 47
Krasnova, I. N., Ladenheim, B., Hodges, A. B., Volkow, N. D., & Cadet, J. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019179 · Cited by 40
Gender-specific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorder
Lin, S.-K., Chen, C.-K., Ball, D., Liu, H.-C., & Loh, E.-W. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500203 · Cited by 40
Self-citationOkada, N., Takahashi, K., Nishimura, Y., Koike, S., Ishii‐Takahashi, A., Sakakibara, E., Satomura, Y., Kinoshita, A., Takizawa, R., Kawasaki, S., et al. (2015) · Addiction Biology · doi:10.1111/adb.12224 · Cited by 39
Decreased cortical complexity in methamphetamine abusers
Yun, K., Park, H.-K., Kwon, D.-H., Kim, Y., Cho, S., Cho, H.-J., Peterson, B. S., & Jeong, J. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.07.009 · Cited by 38
Barrigón, M. L., Gurpegui, M., Ruíz-Veguilla, M., Díaz, F. J., Anguita, M., Sarramea, F., & Cervilla, J. A. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.004 · Cited by 41
Metadata
- Authors
- CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M.
- Affiliations
- Chang Gung Memorial Hospital (TW)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2003-10-30
- Volume
- 33
- Issue
- 8
- Pages
- 1407-1414
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2108964872
- Cited by
- 295
- References
- 23
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 28 · 2019: 14 · 2018: 14 · 2017: 7 · 2016: 13 · 2015: 15 · 2014: 21 · 2013: 19 · 2012: 18
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- methamphetamine, amphetamine psychosis, premorbid personality, schizoid personality disorder, schizotypy, psychiatric comorbidity, major depressive disorder, alcoholism, antisocial personality disorder, auditory hallucinations, persecutory delusions, delusions of reference, age at first use, dosage
- MeSH terms
- Adolescent, Adult, Alcoholism, Central Nervous System Stimulants, Antisocial Personality Disorder, Major Depressive Disorder, Depressive Disorder, Major, Disease Susceptibility, Female, Hospitals, Psychiatric, Humans, Male, Methamphetamine, Personality Assessment, Prisons, Psychiatric Status Rating Scales, Psychoses, Substance-Induced, Risk Factors, Schizoid Personality Disorder, Schizophrenia, Schizophrenic Psychology, Social Adjustment, Taiwan, Comorbidity, Causality, Amphetamine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review